ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,958.18
-0.18%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Ardelyx Inc (ARDX) Share Price

ARDX Ardelyx Inc

7.91
0.12 (1.54%)
18 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Ardelyx Inc NASDAQ:ARDX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.12 1.54 7.91 7.67 7.88 7.86 7.69 7.79 2,291,027 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 124.46M -66.07M -0.2839 -27.51 1.82B
 Type  Size  Price  Time  Units 
 9 35 7.87 23:57:25 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ARDX News
16/05/202413:01GLOBEArdelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
14/05/202421:02GLOBEArdelyx, Inc. Reports Employment Inducement Grants
09/05/202421:03EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
07/05/202421:48EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
07/05/202413:01GLOBEArdelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
02/05/202421:02GLOBEArdelyx Reports First Quarter 2024 Financial Results and Provides Business Update
01/05/202413:00GLOBEArdelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
06/03/202310:16PBBArdelyx Inc5
Data Downloads for ARDX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Ardelyx Inc Articles